Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Glycosylation-modified antigens as a tolerance-inducing vaccine platform prevent anaphylaxis in a pre-clinical model of food allergy.
Cell Rep Med. 2024 Jan 16;5(1):101346. doi: 10.1016/j.xcrm.2023.101346. Epub 2023 Dec 20.
Cell Rep Med. 2024.
PMID: 38128531
Free PMC article.
Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses.
Tremain AC, Wallace RP, Lorentz KM, Thornley TB, Antane JT, Raczy MR, Reda JW, Alpar AT, Slezak AJ, Watkins EA, Maulloo CD, Budina E, Solanki A, Nguyen M, Bischoff DJ, Harrington JL, Mishra R, Conley GP, Marlin R, Dereuddre-Bosquet N, Gallouët AS, LeGrand R, Wilson DS, Kontos S, Hubbell JA.
Tremain AC, et al. Among authors: maulloo cd.
Nat Biomed Eng. 2023 Sep;7(9):1142-1155. doi: 10.1038/s41551-023-01086-2. Epub 2023 Sep 7.
Nat Biomed Eng. 2023.
PMID: 37679570
Item in Clipboard
Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance.
Maulloo CD, Cao S, Watkins EA, Raczy MM, Solanki AS, Nguyen M, Reda JW, Shim HN, Wilson DS, Swartz MA, Hubbell JA.
Maulloo CD, et al.
Front Immunol. 2021 Sep 24;12:714842. doi: 10.3389/fimmu.2021.714842. eCollection 2021.
Front Immunol. 2021.
PMID: 34630389
Free PMC article.
Item in Clipboard
Cite
Cite